published on 02 Aug 2018
Developing the latest framework to measure and incentivise pharmaceutical industry action on R&D
published on 21 Feb 2018
How to accelerate pharmaceutical R&D: A new framework for sharing IP with global health researchers.
published on 02 Jan 2018
Increasing access to cancer care: how can we guide and track actions by pharmaceutical companies?
published on 01 Dec 2017
World AIDS Day 2017: Enabling broad access to best-in-class HIV treatment – Best practice for originators
published on 07 Nov 2017
Why it matters – Pharmaceutical Compliance, Anti-corruption and Access to Medicine
published on 06 Feb 2017
Harvard Business Review: How pharma can fix its reputation and its business at the same time
published on 10 Oct 2016
Access to mental healthcare: how should pharma companies channel their efforts?
published on 02 Aug 2016
Shifting mindsets to improve access to medicine
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.